Alberta Investment Management Corp Atara Biotherapeutics, Inc. Transaction History

Alberta Investment Management Corp

$8.74 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $302,505 - $634,680	-64,500 Reduced 16.84%	318,430 $2.48 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $859,192 - $1.72 Million	101,800 Added 36.21%	382,930 $3.56 Million
Q4 2021 Feb 11, 2022	SELL	$14.7 - $19.89 $4.66 Million - $6.31 Million	-317,200 Reduced 53.01%	281,130 $4.43 Million
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $3.19 Million - $4.77 Million	-266,300 Reduced 30.8%	598,330 $10.7 Million
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $2.13 Million - $2.73 Million	-164,900 Reduced 16.02%	864,630 $13.4 Million

Q1 2021 May 07, 2021	BUY	$14.0 - $20.72 $5.85 Million - $8.66 Million	418,000 Added 68.35%	1,029,530 $14.8 Million
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $1.69 Million - $3.5 Million	-133,300 Reduced 17.9%	611,530 $12 Million
Q3 2020 Oct 26, 2020	SELL	$11.92 - $15.87 $169,264 - $225,354	-14,200 Reduced 1.87%	744,830 $9.65 Million
Q2 2020 Aug 11, 2020	BUY	$7.53 - $14.93 $1.66 Million - $3.3 Million	220,800 Added 41.02%	759,030 $11.1 Million
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $1.92 Million - $2.96 Million	176,200 Added 48.67%	538,230 $8.87 Million
Q3 2019 Oct 23, 2019	BUY	$12.03 - $19.94 $1.24 Million - $2.06 Million	103,100 Added 39.82%	362,030 $5.11 Million
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $2.16 Million - $4.65 Million	113,400 Added 77.92%	258,930 $5.21 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $41.74 $1.03 Million - $1.51 Million	36,100 Added 32.99%	145,530 $5.79 Million
Q4 2018 Feb 14, 2019	BUY	$30.9 - $42.97 $2.35 Million - $3.27 Million	76,100 Added 228.32%	109,430 $3.8 Million
Q3 2018 Nov 16, 2018	SELL	$35.05 - $43.5 $410,084 - $508,950	-11,700 Reduced 25.98%	33,330 $1.38 Million
Q2 2018 Aug 15, 2018	BUY	$35.15 - $51.45 $456,950 - $668,850	13,000 Added 40.59%	45,030 $1.66 Million
Q1 2018 May 16, 2018	SELL	$18.0 - $48.35 $131,400 - $352,955	-7,300 Reduced 18.56%	32,030 $1.25 Million
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $521,122 - $670,576	39,330	39,330 $651,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account